Wen Shen

Medicine & Life Sciences

1. Menopause 100%
2. Estrogens 51%
3. Gynecology 31%
4. Hormones 29%
5. Breast Neoplasms 27%
6. Obstetrics 24%
7. Quality of Life 23%
8. Female Contraceptive Devices 19%
9. Breast 19%
10. Ehlers-Danlos Syndrome 18%
11. Raloxifene Hydrochloride 18%
12. Curriculum 15%
13. Preclinical Drug Evaluations 15%
14. Needs Assessment 15%
15. Mammaplasty 15%
16. Symptom Assessment 15%
17. Medicine 15%
18. Cancer Survivors 14%
19. Chorionic Gonadotropin 14%
20. African Americans 14%
21. Tamoxifen 14%
22. Therapeutics 14%
23. Endometrium 13%
24. Placebos 13%
25. Neuroprotective Agents 13%
26. Nephrectomy 13%
27. Venous Thromboembolism 13%
28. Breast Density 13%
29. Systemic Lupus Erythematosus 12%
30. Genitalia 12%
31. Horns 11%
32. Osteoporosis 11%
33. Multiple Sclerosis 11%
34. Wound Healing 11%
35. Estradiol 11%
36. Cell Biology 11%
37. Life Style 10%
38. Disease Progression 10%
39. Health Care Outcome Assessment 10%
40. Systematic Reviews 9%
41. Epithelial Cells 9%
42. HIV 9%
43. Internship and Residency 8%
44. Clinical Trials 8%
45. Prospective Studies 8%
46. Education 8%
47. Abscess 8%
48. Sweat 7%
49. Cell Line 7%
50. Epithelium 7%